BioSpace News Archive

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q1 2021.

Kathy Giusti, MBA, Founder and Chief Mission Officer of the Multiple Myeloma Research Foundation and Co-Chair the Harvard Business School Kraft Precision Medicine Accelerator; Nancy P. Pelosi, Speaker of the U.S. House of Representatives; and Charles L. Sawyers, MD, FAACR, world-renowned cancer researcher and AACR Past President, received their awards virtually at the AACR Annual Meeting 2021 on April 11, 2021.

Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement and leukotriene systems are implicated, announces that an IND is now open with the U.S. Food and Drug Administration (FDA)

Spineology Inc., an innovator in anatomy-conserving surgery, welcomes two new area vice presidents to its sales leadership team.

Caresyntax, a company dedicated to making surgery smarter and safer by delivering actionable insights with its enterprise-grade digital surgery platform, announced that it has been selected by the American Board of Surgery as one of three partners to provide a platform for its video-based assessment pilot program.

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that Dr. Sebastian Chung from Memorial Sloan Kettering Cancer Center (“MSK”) presented a virtual poster

TriNetX announces that Ospedale San Raffaele, Italy’s leading biomedical research institute and the country’s representative in the European University Hospital Alliance, has joined the TriNetX network to increase its commitment to clinical trial research and to build on its growing position as a leader in the field of gene therapy for rare diseases.

Nexus Pharmaceuticals announced the launch of Succinylcholine Chloride Injection, USP in 200mg/10mL Multiple-Dose Vials. It is an AP-rated generic to QUELICIN™¥.

Embark Veterinary, a leader in dog genetics, announced that the uniquely spotted coat of German Shorthair Pointers, Australian Cattle Dogs, and other breeds known as “roaning” is strongly associated with a genomic region on chromosome 38 and likely regulated by the usherin gene.

Evommune, Inc., a private R&D company and innovation engine in chronic inflammation, today announced that Luis Peña, president and chief executive officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021, at 11:15 a.m. PDT/2:15 p.m. EDT.